The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention

被引:377
作者
Peters, Jeffrey M. [1 ,2 ]
Shah, Yatrik M. [3 ]
Gonzalez, Frank J. [4 ]
机构
[1] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA
[2] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA
[3] Univ Michigan, Dept Mol & Integrat Physiol, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA
[4] NCI, Lab Metab, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
BETA/DELTA PPAR-BETA/DELTA; ENDOTHELIAL GROWTH-FACTOR; CELL-CYCLE ARREST; GAMMA AGONIST TROGLITAZONE; SENSITIZES TUMOR-CELLS; COLON-CANCER CELLS; PHASE-II TRIAL; LIGAND ACTIVATION; BREAST-CANCER; GENE-EXPRESSION;
D O I
10.1038/nrc3214
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are involved in regulating glucose and lipid homeostasis, inflammation, proliferation and differentiation. Although all of these functions might contribute to the influence of PPARs in carcinogenesis, there is a distinct need for a review of the literature and additional experimentation to determine the potential for targeting PPARs for cancer therapy and cancer chemoprevention. As PPAR agonists include drugs that are used for the treatment of metabolic diseases, a more complete understanding of the roles of PPARs in cancer will aid in determining any increased cancer risk for patients undergoing therapy with PPAR agonists.
引用
收藏
页码:181 / 195
页数:15
相关论文
共 231 条
  • [1] Peroxisome Proliferator-Activated Receptors Alpha, Beta, and Gamma mRNA and Protein Expression in Human Fetal Tissues
    Abbott, Barbara D.
    Wood, Carmen R.
    Watkins, Andrew M.
    Das, Kaberi P.
    Lau, Christopher S.
    [J]. PPAR RESEARCH, 2010, 2010
  • [2] Transcriptional network governing the angiogenic, switch in human pancreatic cancer
    Abdollahi, Amir
    Schwager, Christian
    Kleeff, Joerg
    Esposito, Irene
    Domhan, Sophie
    Peschke, Peter
    Hauser, Kai
    Hahnfeldt, Philip
    Hlatky, Lynn
    Debus, Juergen
    Peters, Jeffrey M.
    Friess, Helmut
    Folkman, Judah
    Huber, Peter E.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (31) : 12890 - 12895
  • [3] Peroxisome proliferator activated receptor γ in colonic epithelial cells protects against experimental inflammatory bowel disease
    Adachi, M.
    Kurotani, R.
    Morimura, K.
    Shah, Y.
    Sanford, M.
    Madison, B. B.
    Gumucio, D. L.
    Marin, H. E.
    Peters, J. M.
    Young, H. A.
    Gonzalez, F. J.
    [J]. GUT, 2006, 55 (08) : 1104 - 1113
  • [4] Genomewide Analyses Define Different Modes of Transcriptional Regulation by Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ)
    Adhikary, Till
    Kaddatz, Kerstin
    Finkernagel, Florian
    Schoenbauer, Anne
    Meissner, Wolfgang
    Scharfe, Maren
    Jarek, Michael
    Bloecker, Helmut
    Mueller-Bruesselbach, Sabine
    Mueller, Rolf
    [J]. PLOS ONE, 2011, 6 (01):
  • [5] An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours
    Ahmed, N.
    Riley, C.
    Quinn, M. A.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 98 (08) : 1415 - 1424
  • [6] Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα)
    Aoyama, T
    Peters, JM
    Iritani, N
    Nakajima, T
    Furihata, K
    Hashimoto, T
    Gonzalez, FJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) : 5678 - 5684
  • [7] Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells
    Bae, MA
    Song, BJ
    [J]. MOLECULAR PHARMACOLOGY, 2003, 63 (02) : 401 - 408
  • [8] A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours
    Baetz, Tara
    Eisenhauer, Elizabeth
    Siu, Lillian
    MacLean, Martha
    Doppler, Karen
    Walsh, Wendy
    Fisher, Bryn
    Khan, Azhar Z.
    de Alwis, Dinesh P.
    Weitzman, A.
    Brail, Leslie H.
    Moore, Malcolm
    [J]. INVESTIGATIONAL NEW DRUGS, 2007, 25 (03) : 217 - 225
  • [9] TNF-α in promotion and progression of cancer
    Balkwill, Frances
    [J]. CANCER AND METASTASIS REVIEWS, 2006, 25 (03) : 409 - 416
  • [10] PPARγ is required for placental, cardiac, and adipose tissue development
    Barak, Y
    Nelson, MC
    Ong, ES
    Jones, YZ
    Ruiz-Lozano, P
    Chien, KR
    Koder, A
    Evans, RM
    [J]. MOLECULAR CELL, 1999, 4 (04) : 585 - 595